Invasive bone and joint infections from the French Scedosporiosis/lomentosporiosis Observational Study (SOS) cohort: no mortality with long-term antifungal treatment and surgery.
Damien BlezDidier BronnimannBlandine RammaertValérie ZellerLaurence DelhaesLaurent HustacheFrédéric GrenouilletNicolas TraversierJulie BonhommeTaieb ChouakiThomas PerpointFlorence PersatMarie-Elisabeth BougnouxSophie BayleLuc QuaesaetGilles NevezDavid BoutoilleFlorent MorioLaurence PougnetViviane Queyrel-MoranneB Eate HeymRomain GuillemainÉric DannaouiAntoine RouxDea Garcia-HermosoFanny LanternierPublished in: Medical mycology (2023)
Little is known about localized osteoarticular Scedosporiosis (LOS). Most data come from case reports and small case series. Here we present an ancillary study of the nationwide French Scedosporiosis Observational Study (SOS), describing 15 consecutive cases of LOS diagnosed between January 2005 and March 2017. Adult patients diagnosed with LOS defined by osteoarticular involvement without distant foci reported in SOS were included. Fifteen LOS were analyzed. Seven patients had underlying disease. Fourteen patients had prior trauma as potential inoculation. Clinical presentation was arthritis (n = 8), osteitis (n = 5), and thoracic wall infection (n = 2). The most common clinical manifestation was pain (n = 9), followed by localized swelling (n = 7), cutaneous fistulization (n = 7), and fever (n = 5). The species involved were Scedosporium apiospermum (n = 8), S. boydii (n = 3), S. dehoogii (n = 1), and Lomentospora prolificans (n = 3). The species distribution was unremarkable except for S. boydii, which was associated with healthcare-related inoculations. Management was based on medical and surgical treatment for 13 patients. Fourteen patients received antifungal treatment for a median duration of 7 months. No patients died during follow-up. LOS exclusively occurred in the context of inoculation or systemic predisposing factors. It has a non-specific clinical presentation and is associated with an overall good clinical outcome, provided there is a prolonged course of antifungal therapy and adequate surgical management.
Keyphrases
- end stage renal disease
- healthcare
- newly diagnosed
- ejection fraction
- chronic kidney disease
- stem cells
- type diabetes
- cardiovascular disease
- peritoneal dialysis
- rheumatoid arthritis
- risk factors
- spinal cord
- risk assessment
- patient reported outcomes
- minimally invasive
- coronary artery disease
- bone mineral density
- mesenchymal stem cells
- lymph node
- postmenopausal women
- body composition
- atrial fibrillation
- cross sectional
- patient reported
- surgical site infection
- human health
- trauma patients
- free survival